What happens during a C&P exam for Neuropathic Pain Syndrome?

Do NOT stretch, warm up, or take pain medication before your exam. The VA needs your baseline limitation. Report your WORST day. DeLuca v. Brown requires documentation of functional loss during flare-ups.

EDUCATIONAL TOOL ONLY. Not legal or medical advice. Not affiliated with the VA.

← All Condition Guides

CLAIM RECON INTEL

Neuropathic Pain Syndrome

Q: What are the VA rating percentages for Neuropathic Pain Syndrome?

Neuropathic Pain Syndrome (DC 8599) is rated at 10%, 20%, 40%, 60%, 80% under 38 CFR § 4.124a, DC 8599. Mild neuropathic pain — intermittent neuropathic-character pain (burning, electric, lancinating) in a defined nerve distribution, controlled with PRN medication, no significant functional impairment. Rate analogously to the mild tier of the affected nerve's schedule.

Q: What rates 10% for Neuropathic Pain Syndrome under 38 CFR § 4.124a, DC 8599?

Under 38 CFR § 4.124a, DC 8599 (DC 8599), a 10% rating for Neuropathic Pain Syndrome requires: Mild neuropathic pain — intermittent neuropathic-character pain (burning, electric, lancinating) in a defined nerve distribution, controlled with PRN medication, no significant functional impairment. Rate analogously to the mild tier of the affected nerve's schedule.

Q: What rates 20% for Neuropathic Pain Syndrome under 38 CFR § 4.124a, DC 8599?

Under 38 CFR § 4.124a, DC 8599 (DC 8599), a 20% rating for Neuropathic Pain Syndrome requires: Moderate neuropathic pain — daily symptoms requiring continuous medication (gabapentin/pregabalin/duloxetine/TCA), some functional interference, sleep disruption.

Q: What rates 40% for Neuropathic Pain Syndrome under 38 CFR § 4.124a, DC 8599?

Under 38 CFR § 4.124a, DC 8599 (DC 8599), a 40% rating for Neuropathic Pain Syndrome requires: Moderately severe neuropathic pain — constant baseline pain with breakthrough flares, multi-drug regimen often required, significant impact on work and activities of daily living.

Q: What rates 60% for Neuropathic Pain Syndrome under 38 CFR § 4.124a, DC 8599?

Under 38 CFR § 4.124a, DC 8599 (DC 8599), a 60% rating for Neuropathic Pain Syndrome requires: Severe neuropathic pain — intractable to first/second-line agents, requires opioids or interventional pain management (peripheral nerve block, spinal-cord stimulator, intrathecal pump), markedly impaired function.

Q: What rates 80% for Neuropathic Pain Syndrome under 38 CFR § 4.124a, DC 8599?

Under 38 CFR § 4.124a, DC 8599 (DC 8599), a 80% rating for Neuropathic Pain Syndrome requires: Complete-tier rating by analogy under DC 8520 — disabling pain syndrome equivalent to "the foot dangles and drops" total-loss pattern. Rare; typically reserved for the most severe presentations with proven failure of multiple lines of therapy.

Q: What evidence do I need for a Neuropathic Pain Syndrome VA claim?

Key evidence for a Neuropathic Pain Syndrome claim includes: Service treatment records showing injury or complaints; Imaging (X-ray, MRI, CT); Range of motion measurements; Flare-up documentation per Sharp v. Shulkin; Buddy statements describing limitations. All evidence should document both the condition and its impact on daily functioning.

DC 8599 | 38 CFR § 4.124a, DC 8599 | 

✓ VERIFIED AGAINST 38 C.F.R.§ 4.124a (Neurological conditions and convulsive disorders) · reviewed 2026-05-15 · ClaimRecon Editorial Team

Neuropathic Pain Syndrome is rated by the U.S. Department of Veterans Affairs under DC 8599 of 38 CFR § 4.124a, DC 8599 across 5 severity tiers (10% / 20% / 40% / 60% / 80%). Service connection requires (1) a current diagnosis, (2) an in-service event, injury, or exposure, and (3) a medical nexus opinion linking the two under 38 C.F.R. § 3.303.

OVERVIEW

Chronic pain caused by damage to or dysfunction of the somatosensory nervous system, characterized by burning, shooting, or electric shock-like pain.

RATING CRITERIA (5 LEVELS)

10%

Mild neuropathic pain — intermittent neuropathic-character pain (burning, electric, lancinating) in a defined nerve distribution, controlled with PRN medication, no significant functional impairment. Rate analogously to the mild tier of the affected nerve's schedule.

20%

Moderate neuropathic pain — daily symptoms requiring continuous medication (gabapentin/pregabalin/duloxetine/TCA), some functional interference, sleep disruption.

40%

Moderately severe neuropathic pain — constant baseline pain with breakthrough flares, multi-drug regimen often required, significant impact on work and activities of daily living.

60%

Severe neuropathic pain — intractable to first/second-line agents, requires opioids or interventional pain management (peripheral nerve block, spinal-cord stimulator, intrathecal pump), markedly impaired function.

80%

Complete-tier rating by analogy under DC 8520 — disabling pain syndrome equivalent to "the foot dangles and drops" total-loss pattern. Rare; typically reserved for the most severe presentations with proven failure of multiple lines of therapy.

KEY EVIDENCE TO GATHER

-Service treatment records showing injury or complaints

-Imaging (X-ray, MRI, CT)

-Range of motion measurements

-Flare-up documentation per Sharp v. Shulkin

-Buddy statements describing limitations

-Prescription history

-Physical therapy records

-Employment impact documentation

C&P EXAM TIPS (6)

1.Do NOT stretch, warm up, or take pain medication before your exam. The VA needs your baseline limitation.

2.Report your WORST day. DeLuca v. Brown requires documentation of functional loss during flare-ups.

3.Tell the examiner about flare-ups: frequency, duration, estimated ROM loss. Sharp v. Shulkin (2017) requires estimates.

4.Request active, passive, weight-bearing, and non-weight-bearing ROM testing per Correia v. McDonald (2016).

5.If you use assistive devices (brace, cane), bring them.

6.Describe daily activity impact: work, sleep, household tasks.

Secondary Conditions Explorer

736 secondaries mapped

Calculate Your Rating

VA math + dollar impact

RELATED TOOLS

Rating Calculator Secondaries Map C&P Exam Prep PACT Act Scanner 2026 Rates

SOURCES & EDITORIAL

Rating criteria text quoted verbatim from 38 C.F.R. § 4.124a (Neurological conditions and convulsive disorders). Source verified 2026-05-15 by ClaimRecon Editorial Team during a regulation-text comparison against the Cornell Law CFR mirror; eCFR.gov is the authoritative government source.

→ View § 4.124a on eCFR → Cornell Law mirror → Editorial Standards → Suggest a correction

EDUCATIONAL TOOL ONLY. NOT LEGAL OR MEDICAL ADVICE.
NOT AFFILIATED WITH THE U.S. DEPARTMENT OF VETERANS AFFAIRS.
CLAIM RECON 2026

LOADING